Switching mRNA translation off and on is central to regulated gene expression, but what mechanisms moderate the extent of switch-off? Yao et al. describe how basal expression from interferon-gamma-induced transcripts is maintained during mRNA-specific translational repression. This antagonistic mechanism utilizes a truncated RNA-binding factor generated by a unique alternative polyadenylation event.
For cells to function properly, proteins have to be produced at the right time and place and in the correct amount, necessitating mechanisms for tightly controlling gene expression. In recent years, the importance of translational control and its participation in regulatory networks that act at multiple levels of gene expression has emerged. Regulation can be either global, affecting almost all mRNAs, or specific to an mRNA subset. In many cases, mRNA-specific regulation is effected by RNA-binding proteins that bind control elements that are most commonly located within the 5 0 or 3 0 untranslated regions (UTRs). Most of these RNA-binding proteins are translational repressors that act by blocking recruitment of the translational machinery. Intriguingly, in this issue of Cell, Yao et al. (2012) provide evidence for a mechanism that ensures basal expression, referred to as a ''translational trickle,'' of a subset of proteins by antagonizing their mRNA-specific repression ( Figure 1 ). Interestingly this mechanism is mediated by a truncated dominantnegative form of one of the RNA-binding proteins required for repression, produced in a unique alternative polyadenylation event that converts a Tyr codon into a stop codon. Injury or infection activates the innate immune system, prompting monocytes and macrophages to express proinflammatory proteins that must be tightly regulated, and ultimately switched off, to facilitate resolution of inflammation (Murray and Wynn, 2011) . For instance, interferon-gamma (IFN-g) stimulation induces several transcripts (e.g., ceruloplasmin, VEGF-A) that are later silenced by translational repression through a shared regulatory element located in their 3 0 UTRs. This element is bound by the repressive GAIT (gamma-IFN-activated inhibitor of translation) complex, which interferes with interactions between two eukaryotic initiation factors (eIFs), eIF4G and eIF3, that collaborate to recruit small ribosomal subunits, dramatically downregulating translation (Mukhopadhyay et al., 2009) . Assembly of active GAIT complex comprising glutamyl-prolyl tRNA synthetase (EPRS), NS1-associated protein 1 (NSAP1), ribosomal protein L13a, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) requires kinases whose expression is also subject to GAIT-mediated repression, providing negative feedback that may facilitate cells returning to a basal state.
In further probing GAIT-mediated repression, Yao et al. unexpectedly noted a near-constant low level of VEGF-A protein that was independent of the mRNA levels induced by different IFN-g concentrations. To understand the molecular basis of this translational trickle, mathematical modeling was undertaken using the known regulatory components. Fitting the model to experimental observations exposed a requirement for an additional regulatory event, in which a factor bound to the GAIT element should impede access of the GAIT complex to a small proportion of VEGF-A mRNAs, preventing their repression. This conclusion led to the search for, and the discovery of, such a factor, EPRS
N1
. This C-terminally truncated form of EPRS binds to GAIT elements but fails to interact with other GAIT-complex components due to the absence of the C terminus. EPRS N1 is expressed at constant low levels, and importantly, exogenous EPRS N1 was
shown to antagonize GAIT-mediated repression of reporter and endogenous mRNAs. Hence, whereas the majority of VEGF-A, or other GAIT-element-containing mRNAs, will be bound and repressed by the GAIT complex, a minority will instead be bound by EPRS
, allowing their translation (Figure 1) .
Interestingly, EPRS N1 is produced by an unexpected alternative polyadenylation event in which cleavage at a UAU tyrosine codon (Tyr   864   ) within the EPRS open reading frame, followed by adenylation, converts it to a UAA stop codon. This process generates an mRNA without a 3 0 UTR and was named polyadenylationmediated Tyr-to-stop codon conversion (PAY*). A small number of additional potential PAY*-derived mRNAs were identified but exhibited no obvious functional or ontological relationships. Critically, a morpholino that targets the PAY* site within EPRS N1 pre-mRNA decreases endogenous EPRS N1 and VEGF-A protein expression, showing the importance of this processing event, and of EPRS N1 , in precisely regulating VEGF-A protein levels during GAIT-mediated repression.
Although this work shows antagonism of GAIT-mediated regulation, further work is required to delineate the role of this translational trickle in normal monocyte and macrophage function and its Resting macrophages (unstimulated) transcribe low levels of GAIT-element-containing mRNAs (e.g., VEGF-A), which are translated (ON). Macrophage stimulation by IFN-g (early) upregulates transcription of GAIT-element-containing mRNAs (red line), resulting in increased protein expression (solid blue line). Inactive pre-GAIT complexes are formed between phosphorylated EPRS, which exits the tRNA multisynthetase complex (MSC), and NSAP1. After approximately 16-24 hr IFN-g treatment (late), GAIT-element-containing mRNAs remain abundant, but their translation is repressed (OFF) due to the formation and binding of active GAIT complex, comprising EPRS, NSAP1, GAPDH, and L13a. This step requires the phosphorylation-dependent release of L13a from ribosomes. GAIT-complex-associated L13a blocks small ribosomal subunit recruitment by inhibiting the interaction of the eIF4G subunit of the eIF4F complex with eIF3 (not shown). In an apparently constitutive process, a small amount of EPRS mRNA undergoes PAY* processing where cleavage and polyadenylation at a Tyr codon (UAU) leads to production of a truncated version of EPRS, termed EPRS
. EPRS N1 does not interact with GAIT-complex components but binds GAIT elements (depicted as stem loops), protecting a small proportion of GAIT-element-containing mRNAs (ON) from GAIT-complex binding. This ensures that a low level of protein (e.g., VEGF-A) is synthesized when active GAIT complex is repressing translation. The effect of constant ''translational trickle'' from GAIT-element-containing mRNAs is illustrated graphically: dotted blue line shows the level of translated protein (e.g., VEGF-A) in the absence (À EPRS   N1 ) and solid blue in the presence (+ EPRS mRNA, raising questions pertaining to its potential function in these cells. Studies of other mRNA-specific translational repressors have shown that the extent of regulation is determined by various factors, including levels of active repressor, its RNA-binding affinity, number and position of binding sites, and the mechanism of repression (Hentze et al., 2007; Sonenberg and Hinnebusch, 2009 ). Indeed, in many cases, absolute repression may not be required for normal cellular function. Where tight repression is imperative, repressive factors can target multiple sequential steps during translation, so-called ''failsafe'' mechanisms, to ensure efficient repression (Hentze et al., 2007) . In contrast, EPRS N1 has evolved, perhaps counterintuitively, to protect a small proportion of GAIT-element-containing transcripts from repression and thereby ensures constant low-level expression, adding a new layer of complexity to the mechanisms utilized to regulate mRNA translation. Similarly, antagonism by a dominant-negative form of an RNA-binding protein that competes for a cis-element provides an unexpected twist in translational regulation, although distinct RNA-binding proteins that compete for overlapping binding sites have been reported (e.g., Lyabin et al., 2011) . This type of antagonistic mechanism is, however, reminiscent of transcriptional control, where short forms of transcription factors lacking regulatory domains compete for promoters (e.g., Laitem et al., 2009) . Further studies are required to determine whether this basic principle is more widely applied in translational control. Alternative polyadenylation occurs in roughly 50% of human mRNAs, predominantly within the 3 0 UTR, to alter posttranscriptional regulation (Di Giammartino et al., 2011) , although use of alternative polyadenylation sites within introns can produce different protein products. PAY* represents a new mechanism to generate proteome diversity, in which internal stop codons (UAA) are created by cleavage and polyadenylation at Tyr codons (UAC or UAU), preventing such mRNAs, which encode truncated proteins, from being recognized and destroyed as aberrant by the ''nonstop'' surveillance pathway (Frischmeyer et al., 2002) . Although the detailed mechanism underlying EPRS N1 PAY* is unclear at this point, it does utilize at least one canonical cleavage and polyadenylation factor along with the upstream (A[A/U]UAAA) and downstream (U-or GU-rich) elements required for standard polyadenylation, suggesting potential for conservation of PAY* in other species. However, their suboptimal configuration and absence of one or both of these cis-acting elements in other putative human PAY* mRNAs suggests that additional sequences and factors are likely to be required to drive PAY*, even inefficiently. Precedence for this comes from factors (e.g., RNAbinding proteins, sequence elements, transcription efficiency) that can contribute to, or regulate, 3 0 alternative polyadenylation (Di Giammartino et al., 2011) .
Thus it will be intriguing to examine the PAY* mechanism in greater detail and to determine whether it is a rare event, as suggested by the small number of candidate PAY*-processed mRNAs identified, or a more frequent event that is subject to negative regulation.
It is now widely appreciated that translational control and mRNA processing orchestrate regulatory gene expression networks in a wide variety of biological systems. Interestingly, studies of GAITmediated regulation have revealed new and unexpected complexities at multiple levels of posttranscriptional control, providing an elaborate example of how these events collaborate to ensure precisely regulated gene expression.
